Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy.
about
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival studyFLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression.Limitations in Adjuvant Breast Cancer Therapy: The Predictive Potential of Pharmacogenetics and Pharmacogenomics.Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularizationIodine-125 induces apoptosis via regulating p53, microvessel density, and vascular endothelial growth factor in colorectal cancer.The clinical impact of mean vessel size and solidity in breast carcinoma patients.Breast Tumor Angiogenesis and Tumor-Associated Macrophages: Histopathologist's PerspectiveBreast cancer - one term, many entities?Estimation of immunohistochemical expression of VEGF in ductal carcinomas of the breast.Microvessel density and status of p53 protein as potential prognostic factors for adjuvant anthracycline chemotherapy in retrospective analysis of early breast cancer patients groupThe association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health StudyαB-crystallin, an effector of unfolded protein response, confers anti-VEGF resistance to breast cancer via maintenance of intracrine VEGF in endothelial cells.Clinical biomarkers of angiogenesis inhibition.Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy.Magnetic resonance imaging tumor regression shrinkage patterns after neoadjuvant chemotherapy in patients with locally advanced breast cancer: Correlation with tumor biological subtypes and pathological response after therapy.Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial.Tumor suppressor control of the cancer stem cell niche.Vascular proliferation is increased in basal-like breast cancer.Evaluation of vascular endothelial growth factor gene and protein expression in canine metastatic mammary carcinomas.⁹⁹mTc-3PRGD₂ SPECT to monitor early response to neoadjuvant chemotherapy in stage II and III breast cancer.VEGFR-2 expression in malignant tumours of the canine mammary gland: a prospective survival study.The impact of PI3K inhibitors on breast cancer cell and its tumor microenvironment.
P2860
Q30514241-9FAE6D15-5E69-4033-A2F1-E40BB24D7642Q31110389-91FB28A2-2722-4E07-8C1D-52DF36D1FBF1Q33816926-3095368D-B1D7-4978-B6D8-AD74BB29ABCFQ34095952-111A9C13-47A2-4F6C-9BD5-638962879977Q34206305-6C2371BC-1205-4F73-8505-4ADF03E4407EQ35005250-7AC22CF0-27E4-481F-B408-DEE245A5121EQ35022553-7FB7839D-B845-49ED-83B8-5BB687FE0D9AQ35055683-C1CFAFA9-AFBF-4128-987B-6CCE839CCBD2Q35370118-85FD8498-28ED-4142-A2A7-98E5545550FBQ35681760-2ABD0500-1691-432E-8EA4-29A892409511Q36250209-DBC85531-6B1D-4ADF-B724-1CCB8D9DAD97Q36807110-FBC7FF86-15D1-4B41-8FA6-C5AF3B0AF564Q36838575-EBDFA9F6-EE07-424D-9BC7-65DED1F5B56CQ37139413-0C0B6490-589F-4E51-9F8B-DA563A6F5C5AQ39000232-9A821428-7B7A-402E-AA2B-A71388CB83B4Q40276958-538C8FB1-3A27-4AA9-BCBA-C1395184FA8AQ42483948-54F12875-3B1B-4166-B997-7E65AE712502Q42486439-BF379B2F-464E-4527-BC94-47B11B093585Q42493528-1E588E42-64D0-477E-8FBB-882E946D84F3Q51560543-381472BA-7D8A-4855-91C0-E3A1C66E8B5BQ53515259-2B2CC965-CF9E-444D-AABF-1EFD3E6CA4BFQ54341383-6B6A49AF-20E0-4E28-BBA3-4D9A9C002A46Q55435506-8B9034CA-01BC-4B43-8BB1-2D898ED9DC4F
P2860
Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Prognostic analysis of tumour ...... d with high-dose chemotherapy.
@ast
Prognostic analysis of tumour ...... d with high-dose chemotherapy.
@en
type
label
Prognostic analysis of tumour ...... d with high-dose chemotherapy.
@ast
Prognostic analysis of tumour ...... d with high-dose chemotherapy.
@en
prefLabel
Prognostic analysis of tumour ...... d with high-dose chemotherapy.
@ast
Prognostic analysis of tumour ...... d with high-dose chemotherapy.
@en
P2093
P2860
P356
P1476
Prognostic analysis of tumour ...... d with high-dose chemotherapy.
@en
P2093
E J Shpall
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603875
P407
P577
2007-07-03T00:00:00Z